Skip to main content
Equibles
STME logo

STME · Stimcell Energetics Inc.

Track STME — free

Use STME with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research STME.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.16 At close · Oct 19
Rebalance outlook locked
Going-concern doubt — flagged Oct 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions, together with the Company's dependence on additional financing to meet its obligations, raise substantial doubt about its ability to continue as a going concern within one year after the date these interim consolidated financial statements are issued.”
View the 10-Q filed Oct 14, 2026
Market Cap
$3.42M
Shares
21.14M
Volume · Oct 19 867 Avg daily vol (21 sessions) 4806

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.16 Open$0.20 Day$0.16–0.20 52W close$0.15–0.48 Avg vol 30d4K Short int343 · 0.0% float · 3.8d Short vol80% DataJan 2020–Oct 2026 Filing10-Q · Oct 14

Up next

Latest filing: 10-Q
filed Oct 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$799,291
Trailing 12 months
Revenue growth YoY
-100.0%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+6.0%
Year over year · more shares
Price change (1Y)
-28.1%
Trailing year
Short interest
0.0%
Latest settlement · 3.8 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Poor Quant / Vol Very High
Market backdrop VIX 18.4 · elevated Equity put/call 0.55
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −52%
below
Price vs 50-day avg −43%
below
RSI (14) 40
neutral
MACD trend Negative
52-week position 4%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −42%
trailing
6-month return −58%
trailing
YTD return −60%
this year
Relative strength −66%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of float · ▬ 0.0% MoM · 3.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 24
low risk · 0–100
Fundamentals
Poor
Revenue growth −100%
Y/Y
Free cash flow $-312.1K
Quant / Vol
risk profile
Very High
Volatility 1784%
annualized · 1-yr
Max drawdown −95%
past year
ATR 23.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−52% Bearish
Price vs 50-day avg
−43% Bearish
RSI (14)
40 Neutral
MACD trend
Negative Bearish
52-week position
4% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of float · ▬ 0.0% MoM · 3.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 4% Range high $0
vs 200-day avg -52% vs 50-day avg -43%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
STME
Stimcell Energetics Inc.
this stock
$3.42M -59.5% -100.0% — 0.0%
ABT
Abbott Laboratories
 $179.20B -18.2% +5.7% 33.3 0.8%
MDT
Medtronic plc
 $118.67B -1.5% +8.4% 22.9 3.1%
SYK
Stryker Corp
 $114.28B -13.4% +11.2% 30.9 1.5%
BSX
Boston Scientific Corp
 $66.02B -52.2% +12.5% 18.4 2.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest
Shares short
343
Days to cover
3.8d
Change
0 sh
View
Short Volume
Short vol %
80%
As of
Sep 1, 2026
Short Total
View
Fails to Deliver
FTD shares
2.4K
Value
$815
As of
Dec 19, 2025
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$0
Net income (FY)
$-697.4K
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 14, 2026
This year
6

StimCell Energetics Inc. reported no revenue for the three months ended August 31, 2026, a net loss of (169,518) and a $1,971,527 working capital deficit; conditions raised substantial doubt about its ability to continue as a going concern.

View
Proposed Sales
Value
$13.3K
Shares
142.6K
Filed
Feb 22, 2024
View
Exempt Offerings
Offering
$15.0K
Filed
May 9, 2025
View

Performance

5D 20D 120D MTD YTD
STME -26.4% -42.1% -58.5% -26.4% -59.5%
SPY -1.5% -0.9% +7.7% +0.5% +12.4%
vs SPY -24.9% -41.2% -66.2% -26.9% -71.9%
Key facts CIK 1493712 Visit website Investor relations